Sunesis Pharmaceuticals, Inc. (SNSS)
Q2 2018 Earnings Conference Call
August 7, 2018 4:30 PM ET
Executives
Willie Quinn — Chief Financial Officer and Senior Vice President-Corporate Development
Dayton Misfeldt — Interim Chief Executive Officer
Judy Fox — Chief Scientific Officer
Par Hyare — Vice President, Global Oncology Operations
Analysts
Marc Frahm — Cowen and Company
Hartaj Singh — Oppenheimer & Company
Nathaniel Calloway — Edison Group
Presentation
Operator
Welcome to Sunesis Pharmaceuticals’ Second Quarter 2018 Earnings Conference Call. I would now like to turn the conference over to Willie Quinn, Chief Financial Officer and Senior